Live Webcast of the announcement of RP101 Phase II clinical results
March 12, 2020 9:07 amRedwood Pharma and Prof. Gerhard Garhöfer of the Medical University of Vienna, Austria invite you to listen to the live... View Article
Redwood Pharma and Prof. Gerhard Garhöfer of the Medical University of Vienna, Austria invite you to listen to the live... View Article
RP101 demonstrates efficacy and safety in Phase II study of patients with moderate-to-severe dry eye disease RP101 more than doubles... View Article
RP101 visar effekt och säkerhet i Fas II-prövning hos patienter med måttliga till svåra besvär av kroniskt torra ögon RP101... View Article
RP101 Phase II clinical results